R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

NCT03018626 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

402

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

DRUG: Rituximab
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vindesine
DRUG: Bleomycin

Sponsor

Nanfang Hospital, Southern Medical University